Surgery Partners, Inc. financial data

Symbol
SGRY on Nasdaq
Location
310 Seven Springs Way, Suite 500, Brentwood, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 185 % +5.61%
Quick Ratio 14.8 % +2.5%
Return On Equity -5.72 % -417%
Return On Assets -2.3 % -379%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares +0.85%
Common Stock, Shares, Outstanding 128M shares +0.86%
Entity Public Float 2.6B USD -44.7%
Weighted Average Number of Shares Outstanding, Basic 127M shares +0.67%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +0.67%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 137M USD +4.65%
Operating Income (Loss) 362M USD +4.87%
Income Tax Expense (Benefit) 124M USD +575%
Net Income (Loss) Attributable to Parent -180M USD -434%
Earnings Per Share, Basic -1 USD/shares -450%
Earnings Per Share, Diluted -1 USD/shares -450%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 250M USD +17.1%
Accounts Receivable, after Allowance for Credit Loss, Current 563M USD +7.59%
Inventory, Net 87.3M USD +7.91%
Other Assets, Current 159M USD +5.93%
Assets, Current 1.11B USD +9.17%
Deferred Income Tax Assets, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 272M USD +1.8%
Intangible Assets, Net (Excluding Goodwill) 45.7M USD -16.6%
Goodwill 5.1B USD +6.08%
Other Assets, Noncurrent 38.1M USD +5.83%
Assets 7.95B USD +6.23%
Accounts Payable, Current 175M USD +0.52%
Employee-related Liabilities, Current 59.3M USD -6.02%
Liabilities, Current 573M USD +3.9%
Long-term Debt and Lease Obligation 3.47B USD +14%
Deferred Income Tax Liabilities, Net 37.4M USD
Operating Lease, Liability, Noncurrent 264M USD +2.37%
Other Liabilities, Noncurrent 36.3M USD +72%
Accumulated Other Comprehensive Income (Loss), Net of Tax -13.3M USD -136%
Retained Earnings (Accumulated Deficit) -778M USD -30.2%
Stockholders' Equity Attributable to Parent 1.75B USD -10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.16B USD -0.62%
Liabilities and Equity 7.95B USD +6.23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 6M USD -85.3%
Net Cash Provided by (Used in) Financing Activities 30.2M USD -4.73%
Net Cash Provided by (Used in) Investing Activities -76.4M USD +8.06%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 128M shares +0.86%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -40.2M USD -276%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 250M USD +17.1%
Deferred Tax Assets, Valuation Allowance 285M USD +89.7%
Deferred Tax Assets, Gross 404M USD +5.65%
Operating Lease, Liability 303M USD +2.16%
Payments to Acquire Property, Plant, and Equipment 22.7M USD +8.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -231M USD -206%
Lessee, Operating Lease, Liability, to be Paid 485M USD +18.5%
Operating Lease, Liability, Current 39.6M USD +0.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.3M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 65.2M USD +10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -300K USD -112%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 152M USD +23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 53.9M USD +6.52%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD -0.49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20.3M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 43.9M USD +3.05%
Operating Lease, Payments 15.8M USD +1.28%
Additional Paid in Capital 2.54B USD +1.06%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 161M USD +25.1%
Deferred Tax Assets, Net of Valuation Allowance 119M USD -48.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%